Intratumoral nanofluidic system enhanced tumor biodistribution of PD‐L1 antibody in triple‐negative breast cancer is a research paper published in Bioengineering & Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: R01GM127558
U.S. Department of Defense
Grant: W81XWH‐20‐1‐0600
National Institutes of Health
Grant: 5R01GM127558-02
A nanofluidic platform for tunable drug delivery
FWCI
1.16
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals